Breaking the Throughput Barrier: How Multiplexed Droplet Screening Is Fueling the AI-Bio Revolution

A review of a breakthrough droplet microfluidics platform that achieves 100x faster protein screening, revolutionizing enzyme engineering and data-driven biology.

Ailurus Press
September 4, 2025
  • Opuu, V., et al. (2020). Cell-free Directed Evolution of a Protease in Microdroplets at Ultrahigh Throughput. ACS Synthetic Biology, 9(12), 3533–3542. https://pubs.acs.org/doi/10.1021/acssynbio.0c00538
  • Chen, A., Xu, W., Zhang, X. D., Lao, J., Zhao, X., Milcic, K., and Weitz, D. A. (2025) Ultrahigh-Throughput Multiplexed Screening of Purified Protein from Cell-Free Expression Using Droplet Microfluidics, Journal of the American Chemical Society 147, 28758-28772. https://pubs.acs.org/doi/full/10.1021/jacs.5c04962
  • Wen, K. Y., et al. (2025). AI-driven high-throughput droplet screening of cell-free gene expression. Nature Communications, 16, 58139. https://www.nature.com/articles/s41467-025-58139-0
  • About Ailurus

    Ailurus Bio is a pioneering company building biological programs, genetic instructions that act as living software to orchestrate biology. We develop foundational DNAs and libraries, transforming lab-grown cells into living instruments that streamline complex research and production workflows. We empower scientists and developers worldwide with these bioprograms, accelerating discovery and diverse applications. Our mission is to make biology the truly general-purpose technology, as programmable and accessible as modern computers, by constructing a biocomputer architecture for all.

    For more information, visit: ailurus.bio
    Share this post

    Recent posts

    Subscribe and get new posts and updates from Ailurus.

    Subscribe